Clinical Trial Update: Neuroprotection of Pioglitazone in Acute Ischemic Stroke [Phase 2]

View source ↗

Summary

Phase 2 trial of pioglitazone for neuroprotection in acute ischemic stroke has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: Taipei Medical University Shuang Ho Hospital | Conditions: Stroke | Phase 2 | Status: TERMINATED